Short report: TH2 immune response in patients with dengue during defervescence: Preliminary evidence

25Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

Abstract

A shift from a TH1 to a TH2 immune response has been observed in vitro during dengue virus infection. Estimation of plasma IgE level (n = 28), CD4:CD8 lymphocyte ratio, and the intracellular interferon-γ (IFN-γ):interleukin-4 (IL-4) ratio (n = 9) was conducted in patients with various severities of dengue around the time of defervescence. The CD4:CD8 lymphocyte ratio was significantly lower (median = 0.45, interquartile range [IQR] = 0.4-0.47 versus 1.3,1.0-1.9; P = 0.001), and IgE levels were significantly higher (mean = 300.4, SD = 252.5 versus 143.7, 117.9 IU/mL; P = 0.004) in patients than in healthy controls. The intracellular IFN-γ:IL-4 ratio was significantly lower in patients compared with controls (0.28, 0.13 versus 0.99, 0.4; P = 0.001). These findings suggest that a TH2 immune response occurs in patients with dengue around the time of defervescence. Copyright © 2005 by The American Society of Tropical Medicine and Hygiene.

Cite

CITATION STYLE

APA

Mabalirajan, U., Kadhiravan, T., Sharma, S. K., Banga, A., & Ghosh, B. (2005). Short report: TH2 immune response in patients with dengue during defervescence: Preliminary evidence. American Journal of Tropical Medicine and Hygiene, 72(6), 783–785. https://doi.org/10.4269/ajtmh.2005.72.783

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free